Tmunity raises $135M series A to drive forward T-cell immunotherapy pipeline

MHV portfolio company, Tmunity, raises large A round to progress a promising pipeline of T-cell immunotherapies.

See coverage in FierceBiotech:

https://www.fiercebiotech.com/biotech/tmunity-dials-series-a-round-up-to-135m-to-fuel-progress-t-cell-immunotherapy-pipeline